Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 231
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00641186 | Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD) | ||
| NCT05027139 | A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer | ||
| NCT02544763 | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | ||
| NCT04252586 | A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | ||
| NCT04803786 | A Patient-Centric, Prospective, Observational, Non-Interventional Switch Study of XYWAV in Narcolepsy | ||
| NCT01322139 | Sativex Thorough QT/QTc Study | ||
| NCT05558124 | CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML | ||
| NCT01918735 | A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects | ||
| NCT04610658 | Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC | ||
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT01551524 | Phase I Study of mPEG-R-Crisantaspase Given IV | ||
| NCT00710424 | A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy | ||
| NCT05875974 | A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy | ||
| NCT00506974 | Enhancing Slow Wave Sleep With Sodium Oxybate | ||
| NCT01323465 | Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex | ||
| NCT00272948 | Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide | ||
| NCT02953548 | Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) | ||
| NCT00675948 | Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain | ||
| NCT05656248 | Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms | ||
| NCT02073474 | An Observational Post-Marketing Safety Registry of Sativex® | ||
| NCT03526926 | A Post-Marketing Observational Study of VYXEOS™ | ||
| NCT05099666 | Lurbinectedin + Doxorubicin In Leiomyosarcoma | ||
| NCT01604265 | A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis | ||
| NCT04745026 | Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder | ||
| NCT04447846 | Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation | ||
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | ||
| NCT04006925 | Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate | ||
| NCT03101241 | A Phase 2 RCT Study of CX-8998 for Essential Tremor | ||
| NCT02091206 | A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) | ||
| NCT03929666 | A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | ||
| NCT06961266 | A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1 | ||
| NCT01424566 | A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer | ||
| NCT04657666 | Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis | ||
| NCT02769780 | A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy | ||
| NCT05631327 | A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors | ||
| NCT01898520 | A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years | ||
| NCT05485831 | Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY | ||
| NCT03897127 | Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagnosed AML and Intermediate- or Adverse Genetics | ||
| NCT05869773 | A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy | ||
| NCT03878927 | CPX-351+GO in Subjects 55 Years Old, or Older, With AML | ||
| NCT01888120 | Patient Registry of Intrathecal Ziconotide Management(PRIZM) | ||
| NCT01943682 | Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma | ||
| NCT00132873 | Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy | ||
| NCT06924827 | A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex | ||
| NCT06043427 | Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma | ||
| NCT04894591 | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) | ||
| NCT00822094 | Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML) | ||
| NCT05772429 | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting | ||
| NCT04133480 | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution |
